This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

5th Gene Therapy for Neurological Disorders 2023

161 161 people viewed this event.

Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community.

Time: 9:00 am – 4:00 pm

Venue details: Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States

Prices: USD 2999.00 – USD 6395.00

Speakers: Adam Shaywitz, Chief Medical Officer, Bridge Bioscience Corp, Alfica Sehgal Senior, Vice President and Head of Discovery and Translation Discovery, CAMP4 Therapeutics, Ambreen Sayed-Zahid, Scientist, Voyager Therapeutics, Amy Hicks, Associate Director, Entrada Therapeutics Inc., Anindya Sen, Executive Director, Prevail Therapeutics, Dorota Gruber, Assistant Chief, Pediatric Cardiogenomics, Cohen Children’s Medical Center, and more.

Event Organizer - Hanson Wade Group

Event Website
 

Date

6–9 November 2023
 

City

 

Country

United States of America
 

Topic Area

Health and Medicine

Share With Colleagues